BioNTech SE - ADR vs Flagstar Bank NA — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Flagstar Bank NA trades at $14.23 (market cap $5.89B). The key difference: BioNTech SE - ADR is far larger — about 4× Flagstar Bank NA's market cap, and Flagstar Bank NA pays a 0.28% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | FLG | |
|---|---|---|
Market Cap | $23.31B | $5.89B |
Sector | Health | Financials |
52-Week High | $119.34 | $15.36 |
52-Week Low | $83.89 | $10.72 |
Enterprise Value | $6.60B | — |
Dividend Yield | — | 0.28% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →